ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Heart transplant patients"

  • 2016 American Transplant Congress

    Prevalence of Polyreactive Innate-Like B Cells Among Graft-Infiltrating B Cells in Human Cardiac Allograft Vasculopathy.

    D. Chatterjee,1 C. Moore,2 B. Gao,3 K. Clerkin,1 S. See,1 D. Shaked,1 K. Rogers,1 S. Nunez,1 Y. Veras,1 L. Addonizio,1 M. Givertz,4 Y. Naka,1 D. Mancini,1 R. Vasilescu,5 C. Marboe,5 S. Restaino,1 J. Madsen,2 E. Zorn.1

    1Medicine, Columbia University Medical Center, NY, NY; 2Massachusetts General Hospital Transplant Center, Boston; 3First Hospital of Jilin University, Changchun, China; 4Brigham and Women's Hospital, Boston; 5Pathology & Cell Biology, Columbia University Medical Center, NY.

    Cardiac allograft vasculopathy (CAV) is a leading cause of death in long-term heart transplant survivors. Dense B cell infiltrates are common in heart transplants with…
  • 2016 American Transplant Congress

    Predictors of Donor Heart Utilization in United States.

    J. Trivedi, A. Cheng, E. Schumer, M. Black, H. Massey, M. Slaughter.

    Cardiovascular and Thoracic Surgery, University of Louisville, Louisville, KY.

    BackgroundOptimum use of donor organs can increase the reach of the transplant therapy to more patients on waitlist. The heart transplant (HTx) has remained stagnant…
  • 2016 American Transplant Congress

    Four-Factor Prothrombin Complex Concentrate as a Strategy to Rapidly Reverse Anticoagulation in Patients Undergoing Cardiac Transplantation: Better Than the Conventional Approach?

    T. Sam,1 G. Gonzalez-Stawinski,2 G. Saracino,3 A. Jamil,3 S. Hall,2 K. Cox,1 B. Lima.2

    1Department of Pharmacy, Baylor University Medical Center, Dallas, TX; 2Heart Transplantation and Mechanical Circulatory Support, Baylor University Medical Center, Dallas, TX; 3Baylor Research Institute, Baylor University Medical Center, Dallas, TX.

    PurposeThe purpose of this analysis is to compare outcomes of administering four-factor prothrombin complex concentrate (4F-PCC, Kcentra™) versus standard of care for anticoagulation reversal in…
  • 2016 American Transplant Congress

    The Impact of Donor Origin on Survival after Orthotopic Heart Transplantation.

    O. Kiamanesh, A. Khosla, C. Imai, E. Johansson, S. Virani, M. Davis, A. Cheung, J. Bashir, B. Munt, A. Ignaszewski, A. Kaan, M. Toma.

    University of British Columbia, Vancouver, BC, Canada.

    BackgroundOrthotopic heart transplantation (OHT) is the gold standard for the management of select patients with end-stage heart failure, but limited by an ongoing organ donor…
  • 2016 American Transplant Congress

    Using Gastrointestinal Biopsy to Predict Outcome in Patients Evaluated for Cardiac Transplantation for Amyloidosis: A Report from the International Consortium on Cardiac Amyloidosis Transplantation (iCCAT).

    Y. Li,1 K. Verkouw,1 S. Tabtabai,1 R. Barrios,2 R. Gill,3 J. Koo,4 C. Marboe,5 E. Rodriguez,6 C. Tan,6 T. De Marco,3 J. Estep,2 M. Hanna,6 M. Maurer,5 J. Patel,4 V. Selby,3 M. Semigran,1 J. Stone.1

    1Massachusetts General Hospital, Boston, MA; 2The Methodist Hospital, Houston, TX; 3University of California San Francisco, San Francisco, CA; 4Cedars-Sinai Heart Institute, Los Angeles, CA; 5Columbia University Medical Center, New York, NY; 6Cleveland Clinic, Cleveland, OH.

    Heart transplant (HT) is an established therapy for heart failure due to amyloidosis. The utility of gastrointestinal (GI) biopsy in predicting patient outcomes and guiding…
  • 2016 American Transplant Congress

    Exosomes Expressing Cardiac Self-Antigens (Myosin and Vimentin) and Immuno-Regulatory miRNA Induce Graft Rejection.

    M. Sharma,1,2 M. Gunasekaran,1,2 Z. Xu,1,2 N. Steward,1 W. Liu,1,2 N. Benshoff,1 T. Mohanakumar.1,2

    1Washington Univ Sch Med, St. Louis, MO; 2Norton Thoracic Institute - St. Joseph's Hospital, Phoenix, AZ.

    Heart transplantation (HTx) remains an option for patients with cardiac diseases. However, humoral and cell mediated immune responses represent a major obstacle for long-term survival.…
  • 2016 American Transplant Congress

    Air Pollution – An Additional Risk Factor for Developing Cardiac Allograft Vasculopathy.

    C. Bara, D. Böthig, Y. Scheibner, D. Bobylev, B. Przybylek, A. Haverich.

    Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany.

    Purpose:Cardiac allograft vasculopathy (CAV) remains one of the primary causes of death in long-term follow-up after heart transplantation (HTx) and is the most limiting factor…
  • 2016 American Transplant Congress

    Impact of Transfusion Requirements on Likelihood of Heart Transplantation After Total Artificial Heart.

    J. Cook,1 L. Kang,1 M. Flattery,2 I. Tchoukina.2

    1Internal Medicine, Virginia Commonwealth University, Richmond, VA; 2Pauley Heart Center, Virginia Commonwealth University, Richmond, VA.

    Background:Total artificial heart (TAH) is used as a bridge to heart transplantation in patients with end-stage biventricular failure. Anemia requiring blood transfusions occurs following TAH…
  • 2016 American Transplant Congress

    The Role of Palliative Care in the Thoracic Transplant Multidisciplinary Care Team: Barriers and Benefits.

    A. Manfredi,1 C. Toevs.2

    1Loyola University Medical Center, Maywood, IL; 2Terre Haute Regional Hospital, Terre Haute, IN.

    PURPOSE: Patients under consideration for or who have undergone lung and heart transplantation experience many symptoms, including dyspnea, anxiety, pain and caregiver burden. Integration of…
  • 2016 American Transplant Congress

    Management and Outcomes of Upper Extremity Deep Venous Thrombosis in Heart Transplant Patients.

    A. Panakos,1 D. Kramer,1 M. McCarey,1 P. Mather.2

    1Internal Medicine, Thomas Jefferson University Hospital, Philadelphia, PA; 2Cardiology, Thomas Jefferson University Hospital, Philadelphia, PA.

    Upper extremity deep venous thrombosis (UEDVT) is common in post-heart transplant (OHT) patients, likely due to their multiple intravascular catheters and post-surgical state. The clinical…
  • « Previous Page
  • 1
  • …
  • 23
  • 24
  • 25
  • 26
  • 27
  • …
  • 30
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences